glp 1 and anorexia 504: Adult Eating Disorders in the GLP-1 Era Weight-loss drugs pose dangers to

GLP-1 receptor agonists work by: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing excessive hypoglycaemia Suppressing glucagon release from alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These medications are administered via subcutaneous injection, typically once weekly or once daily depending on the specific formulation

2.0.co;2

However, their analysis focused primarily on early disease stages and did not functionally resolve upstream regulatory drivers or their metabolic implications, particularly in advanced lipedema [22]

The results are similar to the research work of Wang et al